AbbVie Comprehensive Income 2010-2024 | ABBV

AbbVie comprehensive income for the quarter ending September 30, 2024 was $-2.513B, a 11.59% increase year-over-year.

  • AbbVie comprehensive income for 2023 was $-2.305B, a 4.82% increase from 2022.
  • AbbVie comprehensive income for 2022 was $-2.199B, a 24.15% decline from 2021.
  • AbbVie comprehensive income for 2021 was $-2.899B, a 6.99% decline from 2020.

AbbVie Comprehensive Income 2010-2024 | ABBV

  • AbbVie comprehensive income for 2023 was $-2.305B, a 4.82% increase from 2022.
  • AbbVie comprehensive income for 2022 was $-2.199B, a 24.15% decline from 2021.
  • AbbVie comprehensive income for 2021 was $-2.899B, a 6.99% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B